Category - Executive Moves

Executive Moves

iBio appoints accomplished financial executive Robert Lutz as CFBO

Robert Lutz iBio (NYSE American:iBio) appointed Robert Lutz as chief financial and business officer (CFBO), effective March 4, 2021. Mr. Lutz will lead iBio’s finance organization and be responsible for building strong...

February 16, 2021

Executive Moves

Hepion names renowned clinician Dr. Todd Hobbs as CMO

Todd Hobbs Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Todd Hobbs, M.D., to the newly created position of chief medical officer, effective Feb. 16, 2021. In this role, Dr. Hobbs will help lead Hepion as it engages...

February 10, 2021

Executive Moves

PharmaJet names Marian Wentworth to board

Marian Wentworth Closely-held PharmaJet appointed Marian Wentworth, president and CEO of Management Sciences for Health since 2017, to its board. Management Sciences for Health is a non-profit organization that works...

February 9, 2021

Executive Moves

Jim Lilly joins England & Co. in healthcare investment banking

Jim Lilly Jim Lilly joined England & Co., a middle-market investment bank, as a managing director in its New York office. Mr. Lilly brings more than 30 years of experience as a strategic advisor to a wide variety of...

January 19, 2021

Executive Moves

Justin Zelin joins BTIG as biotech analyst

Justin Zelin BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology...

January 15, 2021

Executive Moves

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

Tommy Kenny IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) appointed Tommy Kenny as VP intellectual property and legal affairs, general counsel of IntelGenx Corp., the company’s operating subsidiary. Mr. Kenny has been...

January 13, 2021

Executive Moves

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

Joseph Walewicz Closely-held Fibrocor Therapeutics appointed Joseph Walewicz, a biotech veteran with more than 25 years of experience in finance, capital markets and business development, as CFO. Prior to joining...

January 7, 2021

Executive Moves

iBio names renowned drug discovery and development expert Martin Brenner as CSO

Martin Brenner iBio (NYSE American:IBIO) appointed Martin Brenner, Doctor of Veterinary Medicine, Ph.D., as chief scientific officer, effective Jan. 18, 2021. Dr. Brenner has a strong history of success heading drug...

December 28, 2020

Executive Moves

PDS Biotechnology names Seth Van Voorhees as CFO

Seth Van Voorhees PDS Biotechnology (NASDAQ:PDSB) appointed Seth Van Voorhees, Ph.D., as its new CFO, effective Jan. 1, 2021. He replaces Michael King, who served as interim CFO. Dr. Van Voorhees most recently was CFO...

December 9, 2020

Executive Moves

Benjamin Bowen joins Roth’s healthcare investment banking team

Benjamin Bowen Benjamin Bowen, Ph.D., has joined Roth Capital Partners as managing director, healthcare investment banking. Prior to joining Roth, Dr. Bowen most recently was managing director in the investment banking...

December 4, 2020

Category - Executive Moves

iBio appoints accomplished financial executive Robert Lutz as CFBO

Hepion names renowned clinician Dr. Todd Hobbs as CMO

PharmaJet names Marian Wentworth to board

Jim Lilly joins England & Co. in healthcare investment banking

Justin Zelin joins BTIG as biotech analyst

IntelGenx names Tommy Kenny as VP of intellectual property and legal affairs, general counsel

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

iBio names renowned drug discovery and development expert Martin Brenner as CSO

PDS Biotechnology names Seth Van Voorhees as CFO

Benjamin Bowen joins Roth’s healthcare investment banking team

General

More